AKT1 and Insulin resistance: As previously discussed, insulin resistance is a common hallmark of T2DM and AD, and it is mainly driven by the PI3K/Akt/mTOR signaling pathway [366]; more precisely, neuronal insulin resistance driven mTOR hyperactivity inhibits IRS1 activity by negative feedback.